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THE Yoshida ascites sarcoma develops in the abdominal cavity of rats, form-
ing an ascites fluid with free sarcoma cells numbering 300,000-500,000 cells
per mm3. The transplantation is done by injecting this fluid into the peritoneal
cavity of healthy rats and the transplantation rate is approximately 96 per cent
(Kaziwara, Isaka, Sakai, 1952). This very high rate has led to an interesting
observation at our institute. Over a long period of time transplantations had
always been successful apart from two. These had beenperformed by an untrained
assistant and the author was therefore led to assume that the injections had been
made too deeply in the peritoneal cavity and that the injected ascites fluid had
been deposited somewhere in the intestinal canal. This matter gained further
significance when the two rats proved resistant to repeated intraperitoneal
injections. As the caecum of the rat is that part of the intestine which must be
considered to be the most liable to be exposed when intraperitoneal injections are
performed it seemed reasonable to try the effect of intracaecal injections of
ascites sarcoma fluid.
METHODS
Rats cf the State Vitamin Laboratory strain have been employed, kept on a
standard diet.
The intracaecal injections have been done by laparotomy, injecting 0.5 ml.
ascites fluid, under ether anaesthesia. To test the effect, intraperitoneal injections
were performed after various periods of time.
Determination of antibody titre by the morphological method
Antibodies in serum have been shown by the typical morphological reaction
(oedema of the protoplasm) which occurs when suspended sarcoma cells are
exposed to the simultaneous actions of antibody and complement. This reaction
has been described in a previous work (Lund, 1955) dealingwith attempts to isolate
antigen from carcinoma and sarcoma cells. For some time, however, we have
employed a simplified procedure which will be described in brief.
Blood is drawn by heart puncture and serum inactivated at 56° C. for 30
minutes. Ascites sarcoma fluid is diluted with physiological saline in such quanti-
ties that 1 mm.3 cell suspension contains approximately 600-700 cells.
To 0.01 ml. of this suspension is added
0.1 ml. serum (or serum dilution) and
0-01 ml. fresh guinea-pig serum (complement).
The contents are shaken regularly andthetubes areplaced atroomtemperature
and after 30 minutes submitted to microscopical examination. This must be476 HELGE J. C. LUND
carried out by using a counting-chamber, as it is important to avoid compression
of the cells.
The result is given by three grades (weakest positive reactions: +-, strongest
(i.e. maximum) reaction: +±+).
RESULTS
In the first series of rats intraperitoneal injections were performed 3 weeks
after the intracaecal injection of ascites sarcoma fluid, the result being that the
total number of rats thus treated were resistant to this tumour while all controls
died from the ascites sarcoma.
Another experiment was made in which the intervals between the intracaecal
and the intraperitoneal injections were altered, and it was shown that an interval
of 14 days and upwards is followed by resistance. If the interval is less than 14
days all the rats will die (Table I).
TABLE I.-The Dependence of Resistance upon the Interval between Intracaecal
and Intraperitoneal Injection ofAscites Sarcoma
Number of days between
Rat no. i.c. and i.p. injection of sarcoma Resistance
1 . 30 . +
2 . 30 . +
3 . 21 . +
4 . 20 . +
5 . 20 . +
6 . 20 . +
7 . 17 . +
8 . 17 . +
9 . 16 +
10 . 14 . -
11 . 14 . +
12 . 14 . +
13 . 14 . -
14 . 14 . -
15 . 10 . -
16 . 10 . -
17 . 10 . -
18 . 10 . -
19 . 9 . -
The period ofresistance after the intracaecal injection approximates 3 months,
but if this injection is followed by 2 or 3 intraperitoneal injections of the tumour
the duration of this resistance is considerably increased. Rats thus treated have
proved to be resistant for 10 months after the last intraperitoneal injection.
Over 50 rats have been treated with intracaecal injections of ascites sarcoma
and the total number of all these rats have developed resistance towards intra-
peritoneal transplantations. The resistance has been shown to hold when trans-
plantations are performed by subcutaneous injection of the tumour.
This remarkable resistance is due to the formation of a complement-fixing
antibody which can be demonstrated in the serum of the resistant rats.
Antibody content of rat serum
While no antibody towards Yoshida sarcoma cells can be demonstrated in
the serum of normal rats it is often found in serum 3 weeks after the intracaecal
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TABLE II.-The Antibody Titre of Rat Serum towards Yoshida Sarcoma Cells
3 weeks after Intracaecal Injection of 0.5 ml. Ascites Sarcoma
Rat no. Undiluted serum Serum dilution 1: 10
116 . + +
118 . + -
120
121 . + . +
122 +. -
Afterintraperitoneal injections of the tumour in resistant rats a very signifi-
cant rise of antibody titre occurs. The titre from a good antibody producer will
be as follows:
Serum from RRL4: 1/1 . . . 1/160 1/320 1/640 1/1280
Morph. reaction: +++ . . . +++ +±+ +-+ +
CONCLUSION
These experiments show, in the first place, that intracaecal injection ofsarcoma
cells acts as a vaccination, the rats developing resistance towards otherwise
lethalinje actionsofsarcomacells-secondly,thatthisresistance canbereferredtothe
formation of a complement-fixing antibody appearing in the serum of these rats.
That vaccination against infectious diseases can be done by way of the intestinal
canal is well known-the reader is referred to the very instructive monograph by
Thomson and Thomson (1948)-but successful enteral vaccination against a
malignant tumour does not appear to have been described previously.
The significance of the results here reported first of all seems to be the proof
that malignant cells (rat sarcoma) do contain antigen which will, under special
circumstances, in a homologous organism effect the production of a tumour-
specific antibody. Furthermore, it is of decisive importance to more extensive
immunological cancer research that we have at our disposal a specific antiserum.
This applies especially to the experiments with isolation of the specific antigen.
SUMMARY
Over 50 rats treated by intracaecal injections of Yoshida ascites sarcoma
have developed a total resistance to further transplantations of this tumour.
This resistance is due to the formation of a complement-fixing antibody appearing
in the serum of these rats.
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